Five Chinese SFDA officials arrested for taking bribes

20 April 2010

Five officials from China's State Food and Drug Administration (SFDA) have been arrested on charges of taking bribes, only three years after its former head was executed for the same offence, reported the Shanghai Daily. Another official was ordered by investigators to stay at home pending results of the investigation.

Of the five arrested officials, Wei Liang was the first to be given double designation status in the investigation, which is still undergoing and may take in more officials, a well-informed source told the newspaper. Double designation is when a Party official is ordered to answer allegations of disciplinary violations or corruption at a designated time and place.

Mr Wei used to be a senior clerk in the bio-products division of the SFDA's drug registration department, which mainly deals with setting national standards and registering bio-products including vaccines and blood products.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical